1072855-75-4 Usage
Uses
Used in Pharmaceutical Industry:
6-[(2,2,2-Trifluoroethoxy)methyl]nicotinic acid is used as a key intermediate in the synthesis of drugs for treating a range of diseases. Its unique structure, including the trifluoroethoxy group, allows for the development of novel compounds with enhanced biological activity and therapeutic potential.
Used in Agrochemical Industry:
In the agrochemical sector, 6-[(2,2,2-Trifluoroethoxy)methyl]nicotinic acid is utilized as a precursor in the production of agrochemicals, such as pesticides and herbicides. The trifluoroethoxy group contributes to the molecule's stability and effectiveness, making it a valuable component in the formulation of these products.
Used in Research and Development:
6-[(2,2,2-Trifluoroethoxy)methyl]nicotinic acid is also employed as a building block in the design of new chemical entities for research purposes. Its properties make it a versatile component in the creation of compounds with potential applications in various fields, including medicine, agriculture, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 1072855-75-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,2,8,5 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1072855-75:
(9*1)+(8*0)+(7*7)+(6*2)+(5*8)+(4*5)+(3*5)+(2*7)+(1*5)=164
164 % 10 = 4
So 1072855-75-4 is a valid CAS Registry Number.
1072855-75-4Relevant articles and documents
NOVEL CHROMANE COMPOUND FOR THE TREATMENT OF PAIN DISORDERS
-
, (2012/04/10)
The present invention relates to the compound N-[(3S)-5-(5-methoxypyrazin-2-yl)-3,4- dihydro-2H-chromen-3-yl]-6-[(2,2,2-trifluoroethoxy)methyl]pyridine-3-carboxamide, or a pharmaceutical composition comprising said compound and to the use of said compounds in therapy.
NEW COMPOUNDS 806
-
, (2008/12/08)
The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof.